CPT code 86409: Neutralizing antibody, SARS-CoV-2 titer2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Measures neutralizing antibodies to SARS-CoV-2 and reports a titer when a laboratory test determines neutralizing-antibody activity.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide738 Medicare services in 2024

Medicare pays $79.61 for 86409 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$79.61

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2024
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 86409 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 86409 covers

This laboratory service measures neutralizing antibodies to SARS-CoV-2 and reports the result as a titer. It identifies neutralizing activity rather than reporting only a screening result. Clinical laboratories perform the assay and report it to the ordering clinician; the code distinguishes titration from screening for neutralizing antibodies.

Report 86409 when the service determines a neutralizing-antibody titer; use 86408 for screening rather than titration. The code is paid through the CLFS, which sets one national amount applicable across states, localities, and office or facility settings. The 2026 national CLFS amount is $79.61, unchanged from 2024 and 2025. Medicare pays the test only through the CLFS, not the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 86409

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 86409. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 86409 with status X (excluded by statute), so the test itself is paid only from the CLFS.

86409 on the lab fee schedule since 2020

86409 · CLFS 2026 Q4 (current)

$79.61

Unchanged since Apr 1, 2024

Amount in each year’s latest CLFS release · bars start at $0

Every change on file

  1. Apr 1, 2024 · CLFS 2024 Q2MAC-priced → $79.61

25 quarterly CLFS releases on file, first CLFS 2020 Q4. A code missing from a quarter wasn’t on that release.

86409 compared with similar tests

86408COVID-19 antibodyNeutralizing antibody screen$42.13
86408 is the screening code for SARS-CoV-2 neutralizing antibodies. Use 86409 when the test determines a titer.
86413COVID-19 antibodyQuantitative measurement$51.43
86413 reports quantitative SARS-CoV-2 antibody measurement; 86409 is specific to a neutralizing-antibody titer.
86769COVID-19 antibodyMultiple-step method$42.13
86769 is used for general SARS-CoV-2 antibody testing, not specifically for a neutralizing-antibody titer.

86409 billing questions

When should 86409 be selected instead of 86408?

Use 86409 when the service determines a neutralizing-antibody titer. Code 86408 is for screening for SARS-CoV-2 neutralizing antibodies.

Is 86409 the same as a quantitative SARS-CoV-2 antibody test?

No. Code 86409 reports a neutralizing-antibody titer; 86413 is for quantitative SARS-CoV-2 antibody measurement.

Does Medicare pay 86409 under the physician fee schedule?

No. Medicare pays this test only through the CLFS, at one national rate across localities and office or facility settings.

Can a physician interpretation be billed separately with 86409?

Medicare pays 86409 only through the CLFS; the code is not paid under the physician fee schedule as a separately payable interpretation.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 86409PUF_CLFS_CY2026_Q4V1.csv, line 1,722 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 86409?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 86409 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist